You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FDMT Exercise Disclosure
Bizily Scott · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
Bizily Scott Chief Legal Officer
FDMT
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
FDMT daily price context
Close on/before transaction
$14.35
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 584 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-382245
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$11.97K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Sep 1, 2026 | $3.79K |
| 4d Molecular Therapeutics, Inc. FDMT | Sale | Sep 1, 2026 | $8.18K |
| 4d Molecular Therapeutics, Inc. FDMT Current | Exercise | Sep 1, 2026 | $0 |